UPDATE : Wednesday, April 24, 2019
상단여백
‘Darzalex as another weapon against multiple myeloma’ by Park Gi-taek 2019-04-19 15:39
Brexit to take toll on Korean medical device makers by Park Gi-taek 2019-04-16 16:18
Drop did not kill newborn, says CHA Bundang hospital by Park Gi-taek 2019-04-15 15:20
Antitrust watchdog raids 3 leading stent makers by Park Gi-taek 2019-03-27 14:28
Doctors outrageous over MSD Korea’s recordings of their talks by Park Gi-taek 2019-03-25 16:05
라인
Researchers find biomarker to predict recurrence of chronic myeloid leukemia by Park Gi-taek 2019-02-25 16:03
Direct-to-consumer genetic testing allowed for Parkinson’s, lung cancer by Park Gi-taek 2019-02-12 14:48
Demands for MMR vaccines spike amid resurgence of measles by Park Gi-taek 2019-02-12 11:19
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list by Park Gi-taek 2019-02-08 16:46
Korean firms ink $232 million surgical device export deals in Dubai by Park Gi-taek 2019-02-07 11:55
라인
Ipsen’s renal cancer drug Carbometyx gets insurance benefit by Park Gi-taek 2019-01-31 11:13
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’ by Park Gi-taek 2019-01-22 14:18
‘Half of the subfertile see doctor 3 years after trying pregnancy’ by Park Gi-taek 2019-01-21 11:44
Healcerion’s wireless ultrasound Sonon sold out in Japan by Park Gi-taek 2019-01-18 11:46
‘Tagrisso’s benefit as 1st-line treatment overrides resistance risk’ by Park Gi-taek 2019-01-17 12:34
라인
GenBody releases rapid influenza diagnostic kit by Park Gi-taek 2018-12-17 14:33
Shinpoong’s drug becomes first-line malaria treatment in Côte d'Ivoire by Park Gi-taek 2018-12-17 14:20
Can AI-using medical technologies get coverage? by Park Gi-taek 2018-12-06 13:04
Bukwang completes phase-2b test on new diabetes drug by Park Gi-taek 2018-11-29 15:19
‘Patients may try to sell their medical information’ by Park Gi-taek 2018-11-26 16:21
-12345-
[News Focus] Cholesterol-reducing PCSK9 inhibitors get popular -- cost-effective, too?[News Focus] Cholesterol-reducing PCSK9 inhibitors get popular -- cost-effective, too?
여백
Most viewed
여백
Opinion
[Column] Measles and fake news
[Column] Measles and fake news
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
[Reporter’s Notebook]‘What are you fighting for?’
[Reporter’s Notebook]‘What are you fighting for?’
여백
Back to Top